Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Insite Vision Inc. -- Ignore unavailable to you. Want to Upgrade?

To: JimmyD who wrote (921)	2/9/1999 3:28:00 PM
From: Awashonks	Read Replies (1) \| Respond to of 1060

I thought the shareholder update was good. The numbers aren't releasable at PNU's request. Their relationship with PNU appears to be very good and I wouldn't be surprised to see more progress sooner than later on ISV 900 with PNU. Although I've cried wolf before... :) 900 is the really big deal. Murphy said the stock should be in double digits once the deal is done. Of course it is also reasonable to think that at some point PNU could make ISV a buyout offer if their pipeline is as promising as it seems. It might be cheaper to buy them than to continue to license the products. Just my .02. I'm hoping Murphy will look into this because I think there is more going on than we can see. "These genetic technologies may also have applications in drug discovery, as well as other areas". Hmmmm.... We'll see what we can get from the company. I urge you to call them directly. The more people we talk to the better we can fit the pieces of the puzzle. Awashonks